203 related articles for article (PubMed ID: 7862156)
1. Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF.
Lu J; Maruyama M; Satake M; Bae SC; Ogawa E; Kagoshima H; Shigesada K; Ito Y
Mol Cell Biol; 1995 Mar; 15(3):1651-61. PubMed ID: 7862156
[TBL] [Abstract][Full Text] [Related]
2. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.
Bae SC; Ogawa E; Maruyama M; Oka H; Satake M; Shigesada K; Jenkins NA; Gilbert DJ; Copeland NG; Ito Y
Mol Cell Biol; 1994 May; 14(5):3242-52. PubMed ID: 8164679
[TBL] [Abstract][Full Text] [Related]
3. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain.
Bae SC; Takahashi E; Zhang YW; Ogawa E; Shigesada K; Namba Y; Satake M; Ito Y
Gene; 1995 Jul; 159(2):245-8. PubMed ID: 7622058
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2.
Takahashi A; Satake M; Yamaguchi-Iwai Y; Bae SC; Lu J; Maruyama M; Zhang YW; Oka H; Arai N; Arai K
Blood; 1995 Jul; 86(2):607-16. PubMed ID: 7605990
[TBL] [Abstract][Full Text] [Related]
5. Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development.
Satake M; Nomura S; Yamaguchi-Iwai Y; Takahama Y; Hashimoto Y; Niki M; Kitamura Y; Ito Y
Mol Cell Biol; 1995 Mar; 15(3):1662-70. PubMed ID: 7862157
[TBL] [Abstract][Full Text] [Related]
6. The AML1/ETO(MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2beta(CBFbeta) in the nucleus more efficiently than wild-type AML1.
Tanaka K; Tanaka T; Kurokawa M; Imai Y; Ogawa S; Mitani K; Yazaki Y; Hirai H
Blood; 1998 Mar; 91(5):1688-99. PubMed ID: 9473235
[TBL] [Abstract][Full Text] [Related]
7. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation.
Tanaka Y; Fujii M; Hayashi K; Chiba N; Akaishi T; Shineha R; Nishihira T; Satomi S; Ito Y; Watanabe T; Satake M
Oncogene; 1998 Aug; 17(6):699-708. PubMed ID: 9715271
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.
Kanno Y; Kanno T; Sakakura C; Bae SC; Ito Y
Mol Cell Biol; 1998 Jul; 18(7):4252-61. PubMed ID: 9632809
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.
Ogawa E; Inuzuka M; Maruyama M; Satake M; Naito-Fujimoto M; Ito Y; Shigesada K
Virology; 1993 May; 194(1):314-31. PubMed ID: 8386878
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of the human CD36 gene promoter: identification of a proximal PEBP2/CBF site.
Armesilla AL; Calvo D; Vega MA
J Biol Chem; 1996 Mar; 271(13):7781-7. PubMed ID: 8631821
[TBL] [Abstract][Full Text] [Related]
11. Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1.
Bae SC; Yamaguchi-Iwai Y; Ogawa E; Maruyama M; Inuzuka M; Kagoshima H; Shigesada K; Satake M; Ito Y
Oncogene; 1993 Mar; 8(3):809-14. PubMed ID: 8437866
[TBL] [Abstract][Full Text] [Related]
12. Regulation mechanisms for the heterodimeric transcription factor, PEBP2/CBF.
Bae SC; Ito Y
Histol Histopathol; 1999 Oct; 14(4):1213-21. PubMed ID: 10506937
[TBL] [Abstract][Full Text] [Related]
13. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells.
Nuchprayoon I; Meyers S; Scott LM; Suzow J; Hiebert S; Friedman AD
Mol Cell Biol; 1994 Aug; 14(8):5558-68. PubMed ID: 8035830
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein.
Hajra A; Liu PP; Speck NA; Collins FS
Mol Cell Biol; 1995 Sep; 15(9):4980-9. PubMed ID: 7651416
[TBL] [Abstract][Full Text] [Related]
15. DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cells.
Britos-Bray M; Sacchi N; Friedman AD
Leukemia; 1996 Jun; 10(6):984-90. PubMed ID: 8667656
[TBL] [Abstract][Full Text] [Related]
16. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit.
Kanno T; Kanno Y; Chen LF; Ogawa E; Kim WY; Ito Y
Mol Cell Biol; 1998 May; 18(5):2444-54. PubMed ID: 9566865
[TBL] [Abstract][Full Text] [Related]
18. Structural alterations in the transcription factor PEBP2/CBF linked to four different types of leukemia.
Ito Y
J Cancer Res Clin Oncol; 1996; 122(5):266-74. PubMed ID: 8609149
[TBL] [Abstract][Full Text] [Related]
19. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
Zent C; Rowley JD; Nucifora G
Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
[TBL] [Abstract][Full Text] [Related]
20. Functional dissection of the alpha and beta subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity.
Kagoshima H; Akamatsu Y; Ito Y; Shigesada K
J Biol Chem; 1996 Dec; 271(51):33074-82. PubMed ID: 8955155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]